サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1742536

ドラッグデリバリーシステム市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測

Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 187 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
ドラッグデリバリーシステム市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測
出版日: 2025年04月26日
発行: Transparency Market Research
ページ情報: 英文 187 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ドラッグデリバリーシステム市場- 調査範囲

TMRの調査レポート「ドラッグデリバリーシステムの世界市場」は、2025～2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019～2035年までの世界のドラッグデリバリーシステム市場の収益と予測を提供します。また、2025～2035年までの世界のドラッグデリバリーシステム市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、ドラッグデリバリーシステム市場を推察しました。

市場スナップショット
2024年の市場規模 2,659億米ドル
2035年の市場規模 4,629億米ドル
CAGR 5.1%

当レポートでは、世界のドラッグデリバリーシステム市場の競合情勢について調査しています。世界のドラッグデリバリーシステム市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界のドラッグデリバリーシステム市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界のドラッグデリバリーシステム市場分析と予測、2020～2035年

第5章 主要洞察

  • 主要地域/国におけるヘルスケア費支出
  • デリバリーシステムの技術進歩
  • 主要地域/国における規制シナリオ
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 主要な業界イベント（パートナーシップ、コラボレーション、製品承認、合併および買収）

第6章 世界の市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：タイプ別、2020～2035年
    • 経口ドラッグデリバリーシステム
      • 制御放出ドラッグデリバリー
      • その他
    • 注射ベースドラッグデリバリーシステム
      • 注射ドラッグデリバリーシステム
      • 注射器
    • 経皮ドラッグデリバリーシステム
    • 吸入ドラッグデリバリーシステム
    • 埋め込み型ドラッグデリバリーシステム
    • その他
  • 市場の魅力：タイプ別

第7章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：用途別、2020～2035年
    • 腫瘍性疾患
    • 感染症
    • 呼吸器疾患
    • 心血管疾患
    • 自己免疫疾患
    • 中枢神経系疾患
    • その他
  • 市場の魅力：用途別

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：エンドユーザー別、2020～2035年
    • 病院
    • 外来手術センター
    • 在宅ケア設定
    • その他
  • 市場の魅力：エンドユーザー別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカ地域の市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 会社市場シェア分析（2024）
  • 企業プロファイル
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Terumo Medical Corporation
    • Medtronic plc
    • Koninklijke Philips N.V.
    • Baxter International Inc.
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Teleflex Incorporated
    • Novartis AG
    • Gerresheimer AG
    • Abbott
    • Ypsomed AG
    • SHL Medical
    • Owen Mumford
図表

List of Tables

  • Table 01: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 03: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 04: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 05: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 06: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 07: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 08: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 09: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 10: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 11: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 12: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 13: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 15: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 16: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 17: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 18: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 19: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 20: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 21: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 22: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 23: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 24: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 25: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 27: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 28: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 29: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 30: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 31: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 32: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 33: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 34: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 35: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 36: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 02: Global Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 03: Global Drug Delivery Systems Market Revenue (US$ Bn), by Oral Drug Delivery System, 2020-2035
  • Figure 04: Global Drug Delivery Systems Market Revenue (US$ Bn), by Injection-based Drug Delivery System, 2020-2035
  • Figure 05: Global Drug Delivery Systems Market Revenue (US$ Bn), by Transdermal Drug Delivery System, 2020-2035
  • Figure 06: Global Drug Delivery Systems Market Revenue (US$ Bn), by Inhalation Drug Delivery System, 2020-2035
  • Figure 07: Global Drug Delivery Systems Market Revenue (US$ Bn), by Implantable Drug Delivery System, 2020-2035
  • Figure 08: Global Drug Delivery Systems Market Revenue (US$ Bn), by Ohers, 2020-2035
  • Figure 09: Global Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 10: Global Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 11: Global Drug Delivery Systems Market Revenue (US$ Bn), by Oncological Disorders, 2020-2035
  • Figure 12: Global Drug Delivery Systems Market Revenue (US$ Bn), by Infectious Diseases, 2020-2035
  • Figure 13: Global Drug Delivery Systems Market Revenue (US$ Bn), by Respiratory Disorders, 2020-2035
  • Figure 14: Global Drug Delivery Systems Market Revenue (US$ Bn), by Cardiovascular Disorders, 2020-2035
  • Figure 15: Global Drug Delivery Systems Market Revenue (US$ Bn), by Autoimmune Disorders, 2020-2035
  • Figure 16: Global Drug Delivery Systems Market Revenue (US$ Bn), by CNS Disorders, 2020-2035
  • Figure 17: Global Drug Delivery Systems Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 18: Global Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 19: Global Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 20: Global Drug Delivery Systems Market Revenue (US$ Bn), by Hospitals, 2020-2035
  • Figure 21: Global Drug Delivery Systems Market Revenue (US$ Bn), by Ambulatory Surgical Centers, 2020-2035
  • Figure 22: Global Drug Delivery Systems Market Revenue (US$ Bn), by Homecare Settings, 2020-2035
  • Figure 23: Global Drug Delivery Systems Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 24: Global Drug Delivery Systems Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 25: Global Drug Delivery Systems Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 26: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 27: North America - Drug Delivery Systems Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 28: North America - Drug Delivery Systems Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 29: North America - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 30: North America - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 31: North America - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 32: North America - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 33: North America - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 34: North America - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 35: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 36: Europe - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 37: Europe - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 38: Europe - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 39: Europe - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 40: Europe - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 41: Europe - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 42: Europe - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 43: Europe - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 44: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 45: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 46: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 47: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 48: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 49: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 50: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 51: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 52: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 53: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 54: Latin America - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 55: Latin America - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 56: Latin America - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 57: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 58: Latin America - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 59: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 60: Latin America - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 61: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 62: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 63: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 64: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 65: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 66: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 67: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 68: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 69: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 70: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
目次
Product Code: TMRGL41543

Drug Delivery Systems Market - Scope of Report

TMR's report on the global drug delivery systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug delivery systems market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug delivery systems market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug delivery systems market.

Market Snapshot
Market Value in 2024US$ 265.9 Bn
Market Value in 2035US$ 462.9 Bn
CAGR5.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug delivery systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug delivery systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug delivery systems market.

The report delves into the competitive landscape of the global drug delivery systems market. Key players operating in the global drug delivery systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug delivery systems market profiled in this report.

Key Questions Answered in global drug delivery systems Market Report:

  • What is the sales/revenue generated by drug delivery systems across all regions during the forecast period?
  • What are the opportunities in the global drug delivery systems market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug Delivery Systems Market - Research Objectives and Research Approach

The comprehensive report on the global drug delivery systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug delivery systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug delivery systems market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug Delivery Systems Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Delivery Systems Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements in Drug Delivery Systems
  • 5.3. Regulatory Scenario across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTLE Analysis
  • 5.6. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)

6. Global Drug Delivery Systems Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2035
    • 6.3.1. Oral Drug Delivery System
      • 6.3.1.1. Controlled-release Drug Delivery
      • 6.3.1.2. Other Oral Drug Delivery
    • 6.3.2. Injection-based Drug Delivery System
      • 6.3.2.1. Injectable Drug Delivery System
      • 6.3.2.2. Injectable Devices
    • 6.3.3. Transdermal Drug Delivery System
    • 6.3.4. Inhalation Drug Delivery System
    • 6.3.5. Implantable Drug Delivery System
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Type

7. Global Drug Delivery Systems Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2035
    • 7.3.1. Oncological Disorders
    • 7.3.2. Infectious Diseases
    • 7.3.3. Respiratory Disorders
    • 7.3.4. Cardiovascular Disorders
    • 7.3.5. Autoimmune Disorders
    • 7.3.6. CNS Disorders
    • 7.3.7. Others
  • 7.4. Market Attractiveness By Application

8. Global Drug Delivery Systems Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2035
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Homecare Settings
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Drug Delivery Systems Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Drug Delivery Systems Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type, 2020-2035
    • 10.2.1. Oral Drug Delivery System
      • 10.2.1.1. Controlled-release Drug Delivery
      • 10.2.1.2. Other Oral Drug Delivery
    • 10.2.2. Injection-based Drug Delivery System
      • 10.2.2.1. Injectable Drug Delivery System
      • 10.2.2.2. Injectable Devices
    • 10.2.3. Transdermal Drug Delivery System
    • 10.2.4. Inhalation Drug Delivery System
    • 10.2.5. Implantable Drug Delivery System
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Application, 2020-2035
    • 10.3.1. Oncological Disorders
    • 10.3.2. Infectious Diseases
    • 10.3.3. Respiratory Disorders
    • 10.3.4. Cardiovascular Disorders
    • 10.3.5. Autoimmune Disorders
    • 10.3.6. CNS Disorders
    • 10.3.7. Others
  • 10.4. Market Value Forecast By End-user, 2020-2035
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Drug Delivery Systems Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2035
    • 11.2.1. Oral Drug Delivery System
      • 11.2.1.1. Controlled-release Drug Delivery
      • 11.2.1.2. Other Oral Drug Delivery
    • 11.2.2. Injection-based Drug Delivery System
      • 11.2.2.1. Injectable Drug Delivery System
      • 11.2.2.2. Injectable Devices
    • 11.2.3. Transdermal Drug Delivery System
    • 11.2.4. Inhalation Drug Delivery System
    • 11.2.5. Implantable Drug Delivery System
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Application, 2020-2035
    • 11.3.1. Oncological Disorders
    • 11.3.2. Infectious Diseases
    • 11.3.3. Respiratory Disorders
    • 11.3.4. Cardiovascular Disorders
    • 11.3.5. Autoimmune Disorders
    • 11.3.6. CNS Disorders
    • 11.3.7. Others
  • 11.4. Market Value Forecast By End-user, 2020-2035
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Homecare Settings
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Drug Delivery Systems Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2035
    • 12.2.1. Oral Drug Delivery System
      • 12.2.1.1. Controlled-release Drug Delivery
      • 12.2.1.2. Other Oral Drug Delivery
    • 12.2.2. Injection-based Drug Delivery System
      • 12.2.2.1. Injectable Drug Delivery System
      • 12.2.2.2. Injectable Devices
    • 12.2.3. Transdermal Drug Delivery System
    • 12.2.4. Inhalation Drug Delivery System
    • 12.2.5. Implantable Drug Delivery System
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Application, 2020-2035
    • 12.3.1. Oncological Disorders
    • 12.3.2. Infectious Diseases
    • 12.3.3. Respiratory Disorders
    • 12.3.4. Cardiovascular Disorders
    • 12.3.5. Autoimmune Disorders
    • 12.3.6. CNS Disorders
    • 12.3.7. Others
  • 12.4. Market Value Forecast By End-user, 2020-2035
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Homecare Settings
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Drug Delivery Systems Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2035
    • 13.2.1. Oral Drug Delivery System
      • 13.2.1.1. Controlled-release Drug Delivery
      • 13.2.1.2. Other Oral Drug Delivery
    • 13.2.2. Injection-based Drug Delivery System
      • 13.2.2.1. Injectable Drug Delivery System
      • 13.2.2.2. Injectable Devices
    • 13.2.3. Transdermal Drug Delivery System
    • 13.2.4. Inhalation Drug Delivery System
    • 13.2.5. Implantable Drug Delivery System
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Application, 2020-2035
    • 13.3.1. Oncological Disorders
    • 13.3.2. Infectious Diseases
    • 13.3.3. Respiratory Disorders
    • 13.3.4. Cardiovascular Disorders
    • 13.3.5. Autoimmune Disorders
    • 13.3.6. CNS Disorders
    • 13.3.7. Others
  • 13.4. Market Value Forecast By End-user, 2020-2035
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Homecare Settings
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Drug Delivery Systems Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2035
    • 14.2.1. Oral Drug Delivery System
      • 14.2.1.1. Controlled-release Drug Delivery
      • 14.2.1.2. Other Oral Drug Delivery
    • 14.2.2. Injection-based Drug Delivery System
      • 14.2.2.1. Injectable Drug Delivery System
      • 14.2.2.2. Injectable Devices
    • 14.2.3. Transdermal Drug Delivery System
    • 14.2.4. Inhalation Drug Delivery System
    • 14.2.5. Implantable Drug Delivery System
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Application, 2020-2035
    • 14.3.1. Oncological Disorders
    • 14.3.2. Infectious Diseases
    • 14.3.3. Respiratory Disorders
    • 14.3.4. Cardiovascular Disorders
    • 14.3.5. Autoimmune Disorders
    • 14.3.6. CNS Disorders
    • 14.3.7. Others
  • 14.4. Market Value Forecast By End-user, 2020-2035
    • 14.4.1. Hospitals
    • 14.4.2. Ambulatory Surgical Centers
    • 14.4.3. Homecare Settings
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Market Share Analysis (2024)
  • 15.3. Company Profiles
    • 15.3.1. Becton, Dickinson and Company
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. B. Braun Melsungen AG
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Terumo Medical Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Medtronic plc
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Koninklijke Philips N.V.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Baxter International Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Pfizer Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Teva Pharmaceutical Industries Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Teleflex Incorporated
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Novartis AG
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Gerresheimer AG
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Abbott
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Ypsomed AG
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. SHL Medical
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Owen Mumford
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments